Scynexis, Inc. (SCYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
27 Pages - GLDATA55918
$250.00

Summary

Scynexis, Inc. (Scynexis) is a drug discovery and development company. The company discovers, develops and commercializes novel anti-infective for unmet therapeutic needs. Its pipeline products include SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis C (HCV); SCYX-7158, is used for sleeping sickness; SCY-641, is for human health. Scynexis offers its drug pipeline solutions to pharmaceutical, healthcare and life sciences companies. The company’s pipeline products focus on anti-fungal, anti-viral, and anti-inflammatory treatments. It develops products by using technology platforms such as Enfumafungin platform, Cyclophilin platform and Calcineurin platform. Scynexis is headquartered in Jersey City, New Jersey, the US.

Scynexis, Inc. (SCYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Scynexis, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Scynexis, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Scynexis Raises Additional US$6 Million In Venture Financing 10
Partnerships 11
Scynexis Enters Into Co-Marketing Agreement With R-Pharm For SCY-078 11
Morria BioPharma Enters Into Co-Development Agreement With SCYNEXIS For MRX-4 12
SCYNEXIS Enters Into An Agreement With TB Alliance 13
Licensing Agreements 14
Scynexis Enters into Licensing Agreement with Waterstone Pharma for SCY-635 14
Merck Terminates Licensing Agreement With Scynexis For MK-3118 16
Equity Offering 18
Scynexis Plans to Raise up to USD40 Million in Public Offering of Shares 18
Scynexis Raises USD62 Million in IPO 20
Asset Transactions 22
Avista Pharma Acquires Contract Services Business from Scynexis 22
Accelrys Acquires Hit Explorer Operating System From Scynexis 23
Scynexis, Inc. - Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Scynexis, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Scynexis, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Scynexis, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Scynexis Raises Additional US$6 Million In Venture Financing 10
Scynexis Enters Into Co-Marketing Agreement With R-Pharm For SCY-078 11
Morria BioPharma Enters Into Co-Development Agreement With SCYNEXIS For MRX-4 12
SCYNEXIS Enters Into An Agreement With TB Alliance 13
Scynexis Enters into Licensing Agreement with Waterstone Pharma for SCY-635 14
Merck Terminates Licensing Agreement With Scynexis For MK-3118 16
Scynexis Plans to Raise up to USD40 Million in Public Offering of Shares 18
Scynexis Raises USD62 Million in IPO 20
Avista Pharma Acquires Contract Services Business from Scynexis 22
Accelrys Acquires Hit Explorer Operating System From Scynexis 23
Scynexis, Inc., Key Competitors 24
Scynexis, Inc., Key Employees 25
Scynexis, Inc., Other Locations 26

List of Figures
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Scynexis, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838